Developer of deep learning technology for antibody discovery and optimization.
deepCDR Biologics is tracked in the Tech.eu funding database. Based in Basel, Switzerland; active in Deeptech. Acquired by Alloy Therapeutics in 2021. Data as of 27 Aug 2026.
